Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Lands’ End Lawsuit: Delta Employees Say Uniforms Made Them Sick

A Lands' End (LE) lawsuit is in the works from Delta Air Lines (DAL) employees claiming that the uniforms are making them sick.

L Brands News: LB Stock Jumps 8% on Bank of America Upgrade

L Brands (LB) news for Friday includes a Bank of America upgrade and price target increase that is boosting LB stock up higher.

Incyte News: INCY Stock Tumbles 10% on Experimental Drug Study Failure

Incyte (INCY) news for Friday about a recent clinical trial failing to meet its endpoints has INCY stock taking a beating.

CHWY Stock Dips 1% on Chewy CEO Stock Sale

CHWY stock was down on Friday following news that Chewy (CHWY) CEO Singh Sumit has sold some of his shares for about $3.60 million.

Leap Therapeutics News: LPTX Stock Takes a Massive 58% Leap on BeiGene Deal

Leap Therapeutics (LPTX) news for Friday has LPTX stock soaring following a major deal with BeiGene for its DKN-01 antibody.

CrowdStrike News: CRWD Stock Ticks Up 2% on Nomura Forecast

CrowdStrike (CRWD) news coming out on Friday about a positive 2020 forecast from analysts at Nomura has CRWD stock on the move.

Is the Slump In Pinterest Stock Finally Finished?

The fall 2019 tumble of PINS stock has stabilized with Pinterest trading below its IPO level. But Q4 earnings could result in another hit.

Nokia Has Momentum Early in 2020, but Is It a Buy? 

In 2020, should its 5G business take off as Brad suggests, NOK will quickly move into the safe zone. Nonetheless, I think it’s important to realize that despite having $45 billion in total assets, it is still far from being a perfect investment.

Wait for a Better Price on Apple Stock

Apple stock has been on fire, rallying almost 60% from the August lows. Now, it's time for investors to wait for a better buying opportunity.

How Much Longer Will IBM Shareholders Wait for a Turnaround?

CEO Ginni Rometty's $34 billion bet on open source software provider Red Hat last hasn't been the "game-changer" she promised investors.

How Many Lives Does Nokia Have Remaining?

In the best of circumstances, Nokia shares represented a speculative bet. But in stumbling out of the gates in the ultra-competitive 5G race, the company lost much credibility.

This Is the Biggest Risk for Amazon Stock

AMZN stock had a tough year, at least compared to other mega tech companies. Amazon stock is still facing some notable risks.

3 Top Drug Stocks to Own In 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

What Trump’s Airstrikes in Iran Mean for Investors Now

The killing of Iran's military leader will lead to higher oil prices, but over the longer term, technology will remain a dominant theme.

Advanced Micro Devices Sets a New High

AMD's alliance with Taiwan Semiconductor has given it a lead in central processors over Intel, one that could continue for years.

Why Advanced Micro Devices Stock Can Keep Rising

Advanced Micro Devices stock was the S&P 500's top performer in both 2018 and 2019, but valuation headwinds make a three-peat seem unlikely.

Aphria Stock Has Work to Do to Maintain the Trust of Investors

Aphria stock has risen above other cannabis investments for good reason. But APHA also has some of the same credibility issues that plague its rivals.

Look for This Recovery in Cisco Stock to Carry Well into 2020

Cisco stock ended 2019 in recovery mode, posting a 12% gain for the year with analysts looking for double-digit upside in 2020.

Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock

With shares rebounded, now may not be the time to enter Teva stock. Wait to see how upcoming opioid trials play out. If shares pull back to prior price levels, a buying opportunity may emerge. But for now, the risks do not match up with potential upside.